Showing 731-740 of 1066 results for "".
- NFL Players Wear Cleats to Support Muscular Dystrophy Associationhttps://practicalneurology.com/news/the-muscular-dystrophy-society-represented-in-the-nfls-my-cause-my-cleats-campaign/2470660/During the “My Cause My Cleats” campaign, which took place during the first 2 weeks of December, several National Football League (NFL) players wore custom-designed cleats to support causes important to them. Nyheim Hines, 2024 Muscular Dystrophy Association (M
- Updated World Medical Association Declaration of Helsinki for Medical Research Ethics Releasedhttps://practicalneurology.com/news/updated-world-medical-association-declaration-of-helsinki-for-medical-research-ethics-released/2470621/The World Medical Association (WMA) has released a revised version of the Declaration of Helsinki, the globally recognized ethical framework for medical research involving human participants. Ratified at the WMA's General Assembly in Helsinki on October 19, 2024, the updated declaration addre
- Experimental Combo Treatment Reduced Alzheimer Disease-Associated Agitationhttps://practicalneurology.com/news/experimental-combo-treatment-reduced-alzheimer-disease-associated-agitation/2470535/Results of the ACCORD (NCT04797715) clinical trial presented at the 2024 meeting of the Alzheimer’s Association International Conference (AAIC) demonstrated that AXS-05 (dextromethorphan-bupropion; Axsome Therapeutics, New York, NY) treatment reduced agitation symptom relapse and was well-t
- Investigational Intradiscal Injection Improved Pain Associated with Lumbar Disc Herniationhttps://practicalneurology.com/news/investigational-intradiscal-injection-improved-pain-associated-with-lumbar-disc-herniation/2470528/People treated with experimental product SI-6603 (condoliase; Ferring Pharmaceuticals, Parsippany, NJ; Seikagaku, Tokyo, Japan) by a single intradiscal injection showed improvements in the radicular leg pain associated with their lumbar disc herniation (LDH). Early response data from a phase 3 st
- Antipsychotic Use Associated with Multiple Adverse Outcomes in Dementia Patientshttps://practicalneurology.com/news/antipsychotic-use-associated-with-multiple-adverse-outcomes-in-dementia-patients/2470475/Antipsychotic use in adults with dementia was associated with increased risks of stroke, venous thromboembolism, myocardial infarction, heart failure, fracture, pneumonia, and acute kidney injury, according to study results published in The BMJ. Previous studies established increased ris
- Meta-Analysis Identifies Association Between Personality Traits and Dementia Riskhttps://practicalneurology.com/news/meta-analysis-identifies-association-between-personality-traits-and-dementia-risk/2470364/Specific personality traits, including neuroticism, negative affect, low conscientiousness, and low extraversion, were associated with an increased risk for a dementia diagnosis, according to research published in Alzheimer’s & Dementia. Conversely, positive affect and higher c
- In Utero Exposure to Ocrevus Not Associated with Elevated Adverse Outcomes in Pregnancyhttps://practicalneurology.com/news/in-utero-exposure-to-ocrevus-not-associated-with-elevated-adverse-outcomes-in-pregnancy/2470314/In a study of the largest available dataset for pregnancy outcomes for an anti-CD20 monoclonal antibody therapy, in utero exposure to Ocrevus (ocrelizumab; Genentech, South San Francisco, CA), a medication used to treat multiple sclerosis (MS), was not associated with an elevated risk of preterm
- Vaccinations Not Associated with Multiple Sclerosis Flare-ups According to New Studyhttps://practicalneurology.com/news/vaccinations-not-associated-with-multiple-sclerosis-flare-ups-according-to-new-study/2470300/According to results from a nationwide French study published in JAMA Neurology, there was no association between vaccinations and incidence of severe multiple sclerosis (MS) flare-ups requiring hospitalization. The findings were consistent regardless of age range, whether the participan
- Researchers Confirm 4 Genes Associated with Increased Risk of Developing PMLhttps://practicalneurology.com/news/researchers-confirm-4-genes-associated-with-an-increased-risk-of-developing-pml-researchers-confirm-4-genes-associated-with-an-increased-risk-of-developing-pml/2470291/Researchers have identified 4 genes associated with an increased risk of developing progressive multifocal leukoencephalopathy (PML) in patients taking 99 different PML-linked drugs for a variety of conditions, including multiple sclerosis (MS), blood cancers, and rheumatoid arthritis. This study
- Muscular Dystrophy Association Announces the Start of 30 Days of Strength Campaignhttps://practicalneurology.com/news/mda-announces-the-start-of-30-days-of-strength-campaign/2470289/The Muscular Dystrophy Association (MDA) has announced the start of its 30 Days of Strength campaign for September, which is National Muscular Dystrophy Awareness Month. Throughout the month, the MDA will collaborate with influencers and community leaders, including Nyheim Hines, running back for